02.09.2022 | Correction
Correction: Intrapandemic regional anesthesia as practice: a historical cohort study in patients undergoing breast cancer surgery
Erschienen in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie | Ausgabe 11/2022
Einloggen, um Zugang zu erhaltenExcerpt
In Table 2, column “Intrapandemic group,” the denominators have been corrected to reflect patients who received general anesthesia vs regional anesthesia and sedation (n = 24 and n = 80, respectively)
Outcome
|
Prepandemic group
N = 106
|
Intrapandemic group
N = 104
|
Absolute difference (95% CI)
|
P value
|
---|---|---|---|---|
General anesthesia:
|
77% (69 to 85)
|
< 0.001a
|
||
Yes
|
106/106 (100%)
|
24/104 (23%)
|
||
No
|
0/106 (0%)
|
80/104 (77%)
|
||
General anesthesia:
|
< 0.001a
|
|||
Paravertebral block
|
0/106 (0%)
|
5/24b (21%)
|
-21% (-37 to -5)
|
|
PEC2 block
|
34/106 (32%)
|
11/24b (46%)
|
-14% (-36 to 8)
|
|
Serratus block
|
1/106 (1%)
|
5/24b (21%)
|
-20% (-36 to -4)
|
|
ESP block
|
1/106 (1%)
|
1/24b (4%)
|
-3% (-11 to 5)
|
|
Without block
|
70/106 (66%)
|
2/24b (8%)
|
58% (43 to 72)
|
|
Regional anesthesia and sedation:
|
NA
|
|||
Paravertebral block
|
78/80c (98%)
|
|||
ESP block
|
1/80c (1%)
|
|||
Epidural
|
1/80c (1%)
|
|||
TIVA
|
2/106 (2%)
|
0/24b (0%)
|
2% (-14 to 7)
|
1.00d
|
Volatile
|
104/106 (98%)
|
24/24b (100%)
|
-2% (-7 to 14)
|
1.00d
|
Block failure
|
3/80c (4%)
|
NA
|
||
Total intraoperative fentanyl (µg)
|
121 [99–200]
|
50 [0–150]
|
50 (36 to 78)
|
< 0.001e
|
Number of intraoperatively administered PONV prophylaxis medicationsf
|
< 0.001a
|
|||
0
|
4/106 (4%)
|
16/104 (15%)
|
-12% (-19 to -4)
|
|
1
|
11/106 (10%)
|
43/104 (41%)
|
-31% (-42 to -20)
|
|
2
|
63/106 (59%)
|
32/104 (31%)
|
29% (16 to 42)
|
|
3
|
28/106 (26%)
|
13/104 (13%)
|
14% (3 to 24)
|
|
PONV prophylaxis with 2 or more treatments
|
91/106 (86%)
|
45/104 (43%)
|
43% (31 to 54)
|
< 0.001a
|